Monoclonal antibody-purged bone marrow transplantation therapy for multiple myeloma.

@article{Anderson1993MonoclonalAB,
  title={Monoclonal antibody-purged bone marrow transplantation therapy for multiple myeloma.},
  author={Kenneth C. Anderson and J Andersen and Robert J. Soiffer and Arnold Stephen Freedman and Susan N. Rabinowe and Michael J. Robertson and Neil A. Spector and Katherine Blake and Clifford Murray and Andrew Freeman},
  journal={Blood},
  year={1993},
  volume={82 8},
  pages={2568-76}
}
Forty patients with plasma cell dyscrasias underwent high-dose chemoradiotherapy and either anti-B-cell monoclonal antibody (MoAb)-treated autologous, anti-T-cell MoAb-treated HLA-matched sibling allogeneic or syngeneic bone marrow transplantation (BMT). The majority of patients had advanced Durie-Salmon stage myeloma at diagnosis, all were pretreated with chemotherapy, and 17 had received prior radiotherapy. At the time of BMT, all patients demonstrated good performance status with Karnofsky… CONTINUE READING